These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8829821

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Wakino S, Saruta T.
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):243-7. PubMed ID: 10028932
    [Abstract] [Full Text] [Related]

  • 4. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
    Hayashi K, Ozawa Y, Fujiwara K, Wakino S, Kumagai H, Saruta T.
    Am J Nephrol; 2003 Feb; 23(4):229-44. PubMed ID: 12840599
    [Abstract] [Full Text] [Related]

  • 5. Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Hayashi K, Ozawa Y, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Saruta T.
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):697-702. PubMed ID: 14639089
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Renal microvascular actions of calcium antagonists.
    Loutzenhiser R, Epstein M.
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S3-12. PubMed ID: 16989072
    [Abstract] [Full Text] [Related]

  • 8. Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney.
    Hayashi K, Wakino S, Ozawa Y, Homma K, Kanda T, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T.
    Keio J Med; 2005 Jun; 54(2):102-8. PubMed ID: 16077260
    [Abstract] [Full Text] [Related]

  • 9. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II.
    Takenaka T, Suzuki H, Okada H, Inoue T, Kanno Y, Ozawa Y, Hayashi K, Saruta T.
    Kidney Int; 2002 Aug; 62(2):558-65. PubMed ID: 12110018
    [Abstract] [Full Text] [Related]

  • 10. Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores.
    Inscho EW, Imig JD, Cook AK.
    Hypertension; 1997 Jan; 29(1 Pt 2):222-7. PubMed ID: 9039106
    [Abstract] [Full Text] [Related]

  • 11. Vessel- and vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone.
    Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T, Wakino S, Saruta T.
    J Vasc Res; 2003 Jan; 40(3):244-51. PubMed ID: 12902637
    [Abstract] [Full Text] [Related]

  • 12. Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II.
    Loutzenhiser R, Chilton L, Trottier G.
    Am J Physiol; 1997 Aug; 273(2 Pt 2):F307-14. PubMed ID: 9277592
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T, Kanno Y, Hayashi K, Konishi K.
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [Abstract] [Full Text] [Related]

  • 15. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
    Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Takamatsu I, Ozawa Y, Saruta T.
    J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
    [Abstract] [Full Text] [Related]

  • 16. Effects of insulin on rat renal microvessels: studies in the isolated perfused hydronephrotic kidney.
    Hayashi K, Fujiwara K, Oka K, Nagahama T, Matsuda H, Saruta T.
    Kidney Int; 1997 May; 51(5):1507-13. PubMed ID: 9150466
    [Abstract] [Full Text] [Related]

  • 17. Distinct action of aranidipine and its active metabolite on renal arterioles, with special reference to renal protection.
    Nakamura A, Hayashi K, Fujiwara K, Ozawa Y, Honda M, Saruta T.
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):942-8. PubMed ID: 10836731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.